We've made it easier for you to connect! Fill out your NEW profile.
Genentech Withdraws Breast Cancer Indication From Tecentriq
moderators
Posts: 9,015
Genentech Withdraws Breast Cancer Indication From Tecentriq
August 28, 2021
On Aug. 27, 2021, Genentech announced it is voluntarily withdrawing the breast cancer indication from the immunotherapy medicine Tecentriq in the United States. Read more...
0
Categories
Join Us on Zoom: Upcoming virtual support groups. Read more...
Share more about you! Fill out your NEW profile.